Symposia: Emerging Tools, Techniques, and Artificial Intelligence in Hematology
Oral and Poster Abstracts
Oral
Research, Artificial intelligence (AI), Clinical trials, Lymphoid Leukemias, ALL, Fundamental Science, Acute Myeloid Malignancies, AML, Combination therapy, Apoptosis, Assays, Translational Research, APL, CLL, Clinical Research, Genomics, Bioinformatics, Diseases, Real-world evidence, Treatment Considerations, Computational biology, Lymphoid Malignancies, Biological Processes, Emerging technologies, Myeloid Malignancies, Molecular biology, Technology and Procedures, Multi-systemic interactions, Profiling, Pathogenesis, Imaging, Machine learning, Molecular testing, Omics technologies, Pathology
Room 6DE
(San Diego Convention Center)
Moderators:
Andrew Srisuwananukorn, MD, The Ohio State University
and
Zhijie Wu, MD, PhD, Hematology branch
Disclosures:
No relevant conflicts of interest to declare.
2:00 PM
Xiao Xian Lin, BSc1*, Christopher A. Eide2*, Stephen E. Kurtz, PhD2*, Vedant Sandhu3*, Noor Rashidha Binte Meera Sahib4*, Disha Malani, PhD5, Melissa Gaik-Ming Ooi6*, Edward Chow, PhD3*, Sanjukta Das, PhD7*, Jeffrey W. Tyner, PhD2 and Shruti Bhatt, PhD8
1Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, Singapore, Singapore, Singapore
2Knight Cancer Institute, Oregon Health & Science University, Portland, OR
3Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
4Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
5Dana-Farber Cancer Institute, Boston, MA
6Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
7School of Biotechnology, KIIT University, Odisha, India
8Department of Pharmacy and Pharmaceutical Sciences, National University of Singapore, Singapore, Singapore
2:15 PM
Jingmei Li, PhD1*, Emi Sugimoto, PhD2*, Keita Yamamoto, MD, PhD2*, Yutong Dai, MSc3*, Sung-Joon Park, PhD3*, Kenta Nakai, PhD3*, Toshio Kitamura, MD, PhD4,5 and Susumu Goyama, MD, PhD2*
1Graduate School of Frontier Sciences, The University of Tokyo, Minato-Ku, Japan
2Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
3The institute of Medical Science, The University of Tokyo, Tokyo, Japan
4Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan
5Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan
2:30 PM
Til L. Steinicke1,2,3*, Salvatore Benfatto, PhD1,2*, Maria de los Reyes Capilla Guerra1,4*, Andre B. Monteleone1,4,5*, Subha Shankar6*, Phillip Michaels, MD6, Christoph Schliemann, MD3*, Evan C. Chen, MD7, Gabriel K. Griffin, MD1,4,8* and Volker Hovestadt, PhD1,2,9*
1Broad Institute of MIT and Harvard, Cambridge, MA
2Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
3Department of Medicine A, University Hospital Muenster, Muenster, Germany
4Department of Pathology, Dana-Farber Cancer Institute, Boston, MA
5Albert Einstein College of Medicine, Bronx, NY
6Translational Biomarkers Core, Brigham and Women's Hospital, Boston, MA
7Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
8Department of Pathology, Brigham and Women's Hospital, Boston, MA
9Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA
2:45 PM
Alfonso Piciocchi1*, Monica Messina, PhD1*, Giovanni Marsili1*, Marta Cipriani, MS1,2*, Francesca Paola Paoloni1*, Davide Lazzarotto, MD3*, Anna Candoni, Professor, MD4*, Alessandro Rambaldi5, Matteo Leoncin, MD6*, Paola Fazi1*, Marco Vignetti, MD1*, Robin Foà, MD7* and Sabina Chiaretti, MD, PhD7
1GIMEMA Foundation, Rome, Italy
2University of Rome La Sapienza, Department of Statistical Sciences, Rome, Italy
3Clinica Ematologica e Unità di Terapie Cellulari Presidio Ospedaliero Santa Maria della Misericordia di Udine Azienda Sanitaria Universitaria Friuli Centrale, Udine, ITA
4Section of Haematology, Dept. of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Modena, Italy
5Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
6Ospedale Dell'Angelo, Mestre-Venezia, Italy
7Department of Translational and Precision Medicine, Division of Hematology, Sapienza University, Rome, Italy
3:00 PM
Anja Arner, Dr. rer. nat1*, Bradley Wayne Blaser, MD, PhD2, Andreas Ettinger, PhD3*, Bettina Schmid, Dr. rer. nat4*, Irmela Jeremias, MD5 and Vera Binder-Blaser, Dr. med.6*
1Pediatric Hematology/Oncology, Dr. von Hauner Children’s Hospital, Munich, Germany
2Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
3Institute of Epigenetics and Stem Cells, Helmholtz Centre Munich, German Research Center for Environmental Health, Munich, Germany
4German Center For Neurodegenerative Diseases (DZNE), Munich, Germany
5Research Unit Apoptosis in Hematopoietic Stem Cells (AHS), Helmholtz Munich, German Research Center for Environmental Health (HMGU), Munich, Germany
6Pediatric Hematology/Oncology, Dr. von Hauner Children's Hospital, Munich, Germany
3:15 PM
Caroline Lohoff1,2*, Thi Huong Lan Do3*, Ferris Jung4*, Sandra Kummer3*, Vladimir Benes4*, Wolfgang Huber2*, Thorsten Zenz3 and Junyan Lu1,2*
1Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany
2Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany
3Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
4Genomic Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany
*signifies non-member of ASH
denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.